ArticleJournal of translational medicine2025

High BRAF variant allele frequency predicts poor outcomes in metastatic melanoma patients treated with BRAF/MEK inhibitors.

Michele Guida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.